{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:50:29Z","timestamp":1767145829273,"version":"build-2238731810"},"reference-count":99,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cpcardiol.2023.101739","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T01:42:45Z","timestamp":1681090965000},"page":"101739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reducing Cardiac Steatosis: Interventions to Improve Diastolic Function: A Narrative Review"],"prefix":"10.1016","volume":"48","author":[{"given":"Kiyan","family":"Heshmat-Ghahdarijani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roya","family":"Modaresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobhan","family":"Pourmasjedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setayesh","family":"Sotoudehnia Korani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Rezazadeh Roudkoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razieh","family":"Ziaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armita","family":"Farid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrnaz","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Neshat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.101739_bib0001","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: A report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/07853890.2012.660493","article-title":"Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults","volume":"45","author":"Alagiakrishnan","year":"2013","journal-title":"Ann Med"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0003","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.110.981431","article-title":"Systolic and diastolic heart failure are overlapping phenotypes within the heart failure spectrum","volume":"123","author":"De Keulenaer","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0004","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.106.659763","article-title":"Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota","volume":"115","author":"Lam","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/CRD.0b013e31829cf733","article-title":"Prognostic value of diastolic dysfunction: State of the art review","volume":"22","author":"AlJaroudi","year":"2014","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0006","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijcard.2016.07.252","article-title":"Normal age-related changes in left ventricular function: Role of afterload and subendocardial dysfunction","volume":"223","author":"Parikh","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0007","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1161\/CIRCULATIONAHA.107.738625","article-title":"Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis: Meta-Analysis Research Group in Echocardiography acute myocardial infarction","volume":"117","author":"M\u00f8ller","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0008","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1067\/mhj.2003.46","article-title":"Prognostic importance of systolic and diastolic function after acute myocardial infarction","volume":"145","author":"M\u00f8ller","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0009","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1076-7460.2002.00051.x","article-title":"Primary diastolic heart failure","volume":"11","author":"Chatterjee","year":"2002","journal-title":"Am J Geriatr Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4093\/kdj.2010.34.1.40","article-title":"Risk factors associated with left ventricular diastolic dysfunction in type 2 diabetic patients without hypertension","volume":"34","author":"Noh","year":"2010","journal-title":"Korean Diabetes J"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0011","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1573399810602040367","article-title":"Metabolic obesity: The paradox between visceral and subcutaneous fat","volume":"2","author":"Hamdy","year":"2006","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0012","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.numecd.2022.03.003","article-title":"Lipids and diastolic dysfunction: Recent evidence and findings","volume":"32","author":"Daneii","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0013","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10554-021-02483-x","article-title":"Longitudinal effect of myocardial fat deposition on left ventricular diastolic function: A retrospective cohort study","volume":"38","author":"Hata","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0014","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12872-021-02071-w","article-title":"Association of epicardial fat thickness with left ventricular diastolic function parameters in a community population","volume":"21","author":"Ma","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12933-020-01097-2","article-title":"Pericardial fat and its influence on cardiac diastolic function","volume":"19","author":"de Wit-Verheggen","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12933-018-0735-7","article-title":"Association between epicardial adipose tissue, high-sensitivity C-reactive protein and myocardial dysfunction in middle-aged men with suspected metabolic syndrome","volume":"17","author":"Cho","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0017","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/dom.14885","article-title":"Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes","volume":"25","author":"Moody","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0018","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5551\/jat.40956","article-title":"A high-fat and high-cholesterol diet induces cardiac fibrosis, vascular endothelial, and left ventricular diastolic dysfunction in SHRSP5\/Dmcr rats","volume":"25","author":"Watanabe","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0019","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.0000109213.10461.F6","article-title":"Cardiac systolic and diastolic dysfunction after a cholesterol-rich diet","volume":"109","author":"Huang","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0020","doi-asserted-by":"crossref","first-page":"nzaa090","DOI":"10.1093\/cdn\/nzaa090","article-title":"Diet quality and visceral adiposity among a multiethnic population of young, middle, and older aged adults","volume":"4","author":"Panizza","year":"2020","journal-title":"Curr Dev Nutr"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0021","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/clinem\/dgab681","article-title":"Diet-induced fasting ghrelin elevation reflects the recovery of insulin sensitivity and visceral adiposity regression","volume":"107","author":"Tsaban","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0022","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1007\/s00394-021-02564-6","article-title":"Associations of dietary patterns and nutrients with coronary artery calcification and pericardial adiposity in a longitudinal study of adults with and without type 1 diabetes","volume":"60","author":"Basu","year":"2021","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0023","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1210\/jc.2007-2524","article-title":"Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men","volume":"93","author":"van der Meer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0024","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.2337\/db07-0768","article-title":"Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects","volume":"56","author":"van der Meer","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0025","unstructured":"Proton M. Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects."},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0026","doi-asserted-by":"crossref","first-page":"E714","DOI":"10.1152\/ajpendo.90413.2008","article-title":"Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus","volume":"295","author":"Hammer","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0027","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2337\/dc13-1423","article-title":"Very-low-calorie diet increases myocardial triglyceride content and decreases diastolic left ventricular function in type 2 diabetes with cardiac complications","volume":"37","author":"Jonker","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0028","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/s41366-018-0263-2","article-title":"Very low calorie diets are associated with transient ventricular impairment before reversal of diastolic dysfunction in obesity","volume":"43","author":"Rayner","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0029","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.numecd.2004.10.002","article-title":"Insulin resistance, dietary fat intake and blood pressure predict left ventricular diastolic function 20 years later","volume":"15","author":"Arnl\u00f6v","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0030","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jacc.2009.02.086","article-title":"Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity","volume":"54","author":"Rider","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0031","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/DMSO.S124541","article-title":"Improvement of impaired diastolic left ventricular function after diet-induced weight reduction in severe obesity","volume":"10","author":"Karimian","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2017.01.003","article-title":"Dietary therapy in heart failure with preserved ejection fraction and\/or left ventricular diastolic dysfunction in patients with metabolic syndrome","volume":"234","author":"von Bibra","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0033","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s00246-009-9472-8","article-title":"Right ventricular subclinical diastolic dysfunction in obese children: the effect of weight reduction with a low-carbohydrate diet","volume":"30","author":"Zeybek","year":"2009","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0034","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00380-011-0190-9","article-title":"Cross-sectional relationship of a Mediterranean type diet to diastolic heart function in chronic heart failure patients","volume":"27","author":"Chrysohoou","year":"2012","journal-title":"Heart Vessels"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/nu8030167","article-title":"Quercetin, Inflammation and Immunity","volume":"8","author":"Li","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0036","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7239123","article-title":"Quercetin prevents diastolic dysfunction induced by a high-cholesterol diet: role of oxidative stress and bioenergetics in hyperglycemic rats","volume":"2018","author":"Castillo","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0037","doi-asserted-by":"crossref","first-page":"e61604","DOI":"10.1371\/journal.pone.0061604","article-title":"Association between myocardial triglyceride content and cardiac function in healthy subjects and endurance athletes","volume":"8","author":"Sai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0038","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/met.2018.0092","article-title":"Benefits of 1-year lifestyle modification program on exercise capacity and diastolic function among coronary artery disease men with and without type 2 diabetes","volume":"17","author":"Pich\u00e9","year":"2019","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0039","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1152\/japplphysiol.90756.2008","article-title":"Aerobic exercise training reduces epicardial fat in obese men","volume":"106","author":"Kim","year":"2009","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0040","doi-asserted-by":"crossref","first-page":"e14918","DOI":"10.1097\/MD.0000000000014918","article-title":"A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease","volume":"98","author":"Abdelbasset","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0041","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/10998004211050596","article-title":"Effect of exercise training on spexin level, appetite, lipid accumulation product, visceral adiposity index, and body composition in adults with type 2 diabetes","volume":"24","author":"Mohammadi","year":"2022","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0042","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/gerona\/glab111","article-title":"Effect of aerobic or resistance exercise, or both, on intermuscular and visceral fat and physical and metabolic function in older adults with obesity while dieting","volume":"77","author":"Waters","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0043","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12020-021-02687-0","article-title":"Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial","volume":"72","author":"Ladeiras-Lopes","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0044","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1530\/EJE-10-0624","article-title":"Metformin is associated with improved left ventricular diastolic function measured by tissue Doppler imaging in patients with diabetes","volume":"163","author":"Andersson","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226303","article-title":"Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study","volume":"14","author":"Bassols","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0046","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12933-019-0931-0","article-title":"Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin","volume":"18","author":"Sardu","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0047","doi-asserted-by":"crossref","first-page":"S_604","DOI":"10.1161\/circ.118.suppl_18.S_604","article-title":"Abstract 710: Pioglitazone treatment reduces epicardial fat in patients with type 2 diabetes mellitus and improves left ventricular diastolic function","volume":"118","author":"Nagai","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0048","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1475-2840-9-57","article-title":"Lack of effects of pioglitazone on cardiac function in patients with type 2 diabetes and evidence of left ventricular diastolic dysfunction: a tissue doppler imaging study","volume":"9","author":"Naka","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0049","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/CIRCULATIONAHA.108.803916","article-title":"Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus","volume":"119","author":"van der Meer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1479164111428628","article-title":"The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: a randomised, placebo-controlled trial","volume":"9","author":"McGavock","year":"2012","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0051","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ahj.2010.06.040","article-title":"Diastolic dysfunction: improved understanding using emerging imaging techniques","volume":"160","author":"Daneshvar","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0052","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S2213-8587(21)00179-0","article-title":"Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial","volume":"9","author":"Neeland","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0053","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8838026","article-title":"Diastolic cardiac function improvement by liraglutide is mainly body weight reduction dependent but independently contributes to b-type natriuretic peptide reduction in patients with type 2 diabetes with preserved ejection fraction","volume":"2021","author":"Yagi","year":"2021","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0054","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/oby.21718","article-title":"Liraglutide causes large and rapid epicardial fat reduction","volume":"25","author":"Iacobellis","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4019248","article-title":"Exenatide with metformin ameliorated visceral adiposity and insulin resistance","volume":"2018","author":"Du","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0056","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/dom.12680","article-title":"Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: A prospective randomized clinical trial using magnetic resonance imaging and spectroscopy","volume":"18","author":"Dutour","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0057","first-page":"586","article-title":"[Effects of GLP-1 agonist exenatide on cardiac diastolic function and vascular endothelial function in diabetic patients]","volume":"46","author":"Wang","year":"2015","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0058","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12020-015-0710-y","article-title":"Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: A pilot study","volume":"51","author":"Lima-Mart\u00ednez","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0059","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12933-017-0546-2","article-title":"Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: A subgroup analysis of the PROLOGUE study","volume":"16","author":"Yamada","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0060","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s13300-017-0279-y","article-title":"Ipragliflozin reduces epicardial fat accumulation in non-obese type 2 diabetic patients with visceral obesity: A pilot study","volume":"8","author":"Fukuda","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0061","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/dom.13750","volume":"21","author":"Koshizaka","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0062","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10554-020-02034-w","article-title":"Empagliflozin and left ventricular diastolic function following an acute coronary syndrome in patients with type 2 diabetes","volume":"37","author":"Lan","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0063","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/ejhf.1328","article-title":"Empagliflozin directly improves diastolic function in human heart failure","volume":"20","author":"Pabel","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0064","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12933-021-01237-2","article-title":"Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study","volume":"20","author":"Gaborit","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1253\/circj.71.144","article-title":"Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes","volume":"71","author":"Chen","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0066","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.atherosclerosis.2011.02.036","article-title":"Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect","volume":"216","author":"Mannheim","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115132","article-title":"Long-term atorvastatin or the combination of atorvastatin and nicotinamide ameliorate insulin resistance and left ventricular diastolic dysfunction in a murine model of obesity","volume":"402","author":"Yang","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0068","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1248\/bpb.b15-00126","article-title":"Effects of statins on left ventricular diastolic function in patients with dyslipidemia and diastolic dysfunction (Stat-LVDF Study)","volume":"38","author":"Morimoto","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111179","article-title":"Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia","volume":"135","author":"Werida","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/clc.20287","article-title":"Assessment of regional systolic and diastolic functions affected by atorvastatin in coronary artery disease using tissue Doppler imaging","volume":"31","author":"Qie","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0071","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013104","article-title":"Statins reduce epicardial adipose tissue attenuation independent of lipid lowering: A potential pleiotropic effect","volume":"8","author":"Raggi","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0072","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jacc.2012.12.051","article-title":"Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning)","volume":"61","author":"Alexopoulos","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0073","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4250\/jcu.2010.18.4.121","article-title":"Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: Comparison of atorvastatin with simvastatin\/ezetimibe","volume":"18","author":"Park","year":"2010","journal-title":"J Cardiovasc Ultrasound"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0074","first-page":"1396","article-title":"Improvement of myocardial lipid accumulation and prevention of PGC-1\u03b1 induction by fenofibrate","volume":"5","author":"Li","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0075","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2337\/dc08-0118","article-title":"Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction","volume":"31","author":"Chew","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120269","article-title":"Renin-angiotensin system modulation through enalapril and\/or exercise training improves visceral adiposity in obese mice","volume":"291","author":"Alexandre-Santos","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0077","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s11357-011-9283-8","article-title":"Differential effects of late-life initiation of low-dose enalapril and losartan on diastolic function in senescent Fischer 344 x Brown Norway male rats","volume":"34","author":"Groban","year":"2012","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0078","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ahj.2003.10.031","article-title":"Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: Results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy","volume":"147","author":"M\u00f8ller","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0079","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40292-021-00437-x","article-title":"Impact of sacubitril-valsartan treatment on diastolic function in patients with heart failure and reduced ejection fraction","volume":"28","author":"Pericas","year":"2021","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4250\/jcvi.2020.0005","article-title":"Addition of amlodipine or valsartan for improvement of diastolic dysfunction associated with hypertension","volume":"28","author":"Oh","year":"2020","journal-title":"J Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0081","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12933-021-01270-1","article-title":"Sacubitril\/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness","volume":"20","author":"Aroor","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0082","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1475-2840-12-172","article-title":"Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes","volume":"12","author":"Ram\u00edrez","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0083","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcmg.2017.10.007","article-title":"Association of active and passive components of LV diastolic filling with exercise intolerance in heart failure with preserved ejection fraction: Mechanistic insights from spironolactone response","volume":"12","author":"Kosmala","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0084","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s10554-021-02176-5","article-title":"The effect of spironolactone on diastolic function in haemodialysis patients","volume":"37","author":"Hauser","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/jhh.2014.83","article-title":"Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy","volume":"29","author":"Gupta","year":"2015","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0086","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.soard.2020.09.018","article-title":"Weight loss following bariatric surgery decreases pericardial fat thickness lowering the risk of developing coronary artery disease","volume":"17","author":"Sarmiento-Cobos","year":"2021","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0087","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/cen.12402","article-title":"Effects of bariatric surgery on pericardial ectopic fat depositions and cardiovascular function","volume":"81","author":"van Schinkel","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0088","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jacc.2012.06.016","article-title":"Effects of bariatric surgery on cardiac ectopic fat: Lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content","volume":"60","author":"Gaborit","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154773","article-title":"Early benefits of bariatric surgery on subclinical cardiac function: Contribution of visceral fat mobilization","volume":"119","author":"Pich\u00e9","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5603\/CJ.a2017.0059","article-title":"Improvement of left ventricular diastolic function and left heart morphology in young women with morbid obesity six months after bariatric surgery","volume":"25","author":"Kurnicka","year":"2018","journal-title":"Cardiol J"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0091","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cjca.2012.11.010","article-title":"Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic function","volume":"29","author":"Martin","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0092","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/gerona\/glab111","article-title":"Effect of aerobic or resistance exercise, or both, on intermuscular and visceral fat and physical and metabolic function in older adults with obesity while dieting","volume":"77","author":"Waters","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0093","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/clinem\/dgab681","article-title":"Diet-induced fasting ghrelin elevation reflects the recovery of insulin sensitivity and visceral adiposity regression","volume":"107","author":"Tsaban","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0094","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/10998004211050596","article-title":"Effect of Exercise training on Spexin level, appetite, lipid accumulation product, visceral adiposity index, and body composition in adults with type 2 diabetes","volume":"24","author":"Mohammadi","year":"2022","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0095","article-title":"Renin-angiotensin system modulation through enalapril and\/or exercise training improves visceral adiposity in obese mice","volume":"291","author":"Alexandre-Santos","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-017-0546-2","article-title":"Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study","volume":"16","author":"Yamada","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0097","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1479164111428628","article-title":"The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: a randomised, placebo-controlled trial","volume":"9","author":"McGavock","year":"2012","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0098","doi-asserted-by":"crossref","first-page":"S604","DOI":"10.1161\/circ.118.suppl_18.S_604","article-title":"Abstract 710: pioglitazone treatment reduces epicardial fat in patients with type 2 diabetes mellitus and improves left ventricular diastolic function","volume":"118","author":"Nagai","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101739_bib0099","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.jacc.2003.11.043","volume":"43","author":"Ogata","year":"2004","journal-title":"J Am Coll Cardiol"}],"updated-by":[{"DOI":"10.1016\/j.cpcardiol.2023.101926","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623001561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623001561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T10:59:22Z","timestamp":1695985162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":99,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0146280623001561"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101739","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing Cardiac Steatosis: Interventions to Improve Diastolic Function: A Narrative Review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101739"}}